LONDON, Sept. 26 – For the past few years, European venture capital firms have been hustling to catch up with their American counterparts, establishing life science divisions and stepping up their investments in biotechnology companies.

Yet despite the enthusiasm for downstream companies promising novel medical technologies and treatments, European investors remain skittish about genomics and proteomics.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.